Inflammatory markers and adipokines alter adipocyte-derived ASP production through direct and indirect immune interaction

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 4, 2013, Pages 194-200

  Lu, H ^a,b   Gauvreau, D ^a   Tom, F Q ^a   Lapointe, M ^a   Luo, X P ^b   Cianflone, K ^a  

^a LAVAL UNIVERSITY   (Canada)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

adipocytokines; inflammation; obesity

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 10; INTERLEUKIN 8; LEPTIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID METABOLISM; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CHEMOKINE CCL5; COCULTURE TECHNIQUES; COMPLEMENT C3A; COMPLEMENT C5A; CULTURE MEDIA, CONDITIONED; INFLAMMATION; INTERLEUKIN-10; LEPTIN; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876414141     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1333231     Document Type: Article

References (44)

1. Weisberg S. P., McCann D., Desai M. et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest: 2003; 112 1796 1808 (Pubitemid 38063703)
2. Hotamisligil G. S., Arner P., Caro J. F. et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest: 1995; 95 2409 2415
3. Sartipy P., Loskutoff D. J. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J Biol Chem: 2003; 278 52298 52306 (Pubitemid 38035818)
4. Kim C. S., Park H. S., Kawada T. et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond): 2006; 30 1347 1355 (Pubitemid 44306516)
5. Zeyda M., Stulnig T. M. Adipose tissue macrophages. Immunol Lett: 2007; 112 61 67 (Pubitemid 47379852)
6. Gao Y., Gauvreau D., Cianflone K. Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes. J Cell Biochem: 2010; 109 896 905
7. Murray I., Sniderman A. D., Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Am J Physiol: 1999; 277 E474 E480 (Pubitemid 29458207)
8. Cianflone K., Xia Z., Chen L. Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta: 2003; 1609 127 143 (Pubitemid 36120719)
9. Schrauwen P., Hesselink M. K., Jain M. et al. Acylation-stimulating protein: effect of acute exercise and endurance training. Int J Obes (Lond): 2005; 29 632 638 (Pubitemid 40769485)
10. Cianflone K., Maslowska M. Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest: 1995; 25 817 825
11. Kalant D., MacLaren R., Cui W. et al. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem: 2005; 280 23936 23944 (Pubitemid 40884882)
12. Zhu S., Sun F., Li W. et al. Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem: 2011; 353 305 313
13. Sommer G., Garten A., Petzold S. et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond): 2008; 115 13 23 (Pubitemid 351930789)
14. Yang R. Z., Lee M. J., Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab: 2006; 290 E1253 E1261 (Pubitemid 43847911)
15. Whitehead J. P., Richards A. A., Hickman I. J. et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab: 2006; 8 264 280
16. Brochu-Gaudreau K., Rehfeldt C., Blouin R. et al. Adiponectin action from head to toe. Endocrine: 2010; 37 11 32
17. Peake P. W., Shen Y., Walther A. et al. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun: 2008; 367 560 565
18. Bluher M., Fasshauer M., Tonjes A. et al. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes: 2005; 113 534 537 (Pubitemid 41585991)
19. Calcaterra V., De Amici M., Klersy C. et al. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed: 2009; 80 117 123
20. Dalmas E., Rouault C., Abdennour M. et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr: 2011; 94 450 458
21. Belgardt B. F., Bruning J. C. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci: 2010; 1212 97 113
22. Agrawal S., Gollapudi S., Su H. et al. Leptin activates human B cells to secrete TNF-a, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol: 2011; 31 472 478
23. Tulipano G., Vergoni A. V., Soldi D. et al. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet. J Endocrinol: 2004; 183 289 298 (Pubitemid 39562711)
24. Waage A. Tumour necrosis factor and septic shock. Lancet: 1998; 351 603 (Pubitemid 28077586)
25. Sewter C. P., Digby J. E., Blows F. et al. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol: 1999; 163 33 38 (Pubitemid 29481300)
26. Medina E. A., Stanhope K. L., Mizuno T. M. et al. Effects of tumor necrosis factor alpha on leptin secretion and gene expression: relationship to changes of glucose metabolism in isolated rat adipocytes. Int J Obes Relat Metab Disord: 1999; 23 896 903 (Pubitemid 29378267)
27. Rosenstock M., Greenberg A. S., Rudich A. Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. Diabetologia: 2001; 44 55 62 (Pubitemid 32141885)
28. Hirokawa J., Sakaue S., Furuya Y. et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem: 1998; 123 733 739 (Pubitemid 28197493)
29. Winkler G., Lakatos P., Salamon F. et al. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med: 1999; 16 207 211
30. Creely S. J., McTernan P. G., Kusminski C. M. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab: 2007; 292 E740 E747 (Pubitemid 46411051)
31. Vitseva O. I., Tanriverdi K., Tchkonia T. T. et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring): 2008; 16 932 937 (Pubitemid 351620468)
32. Kopp A., Buechler C., Neumeier M. et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring): 2009; 17 648 656
33. Yang Y., Lu H. L., Zhang J. et al. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond): 2006; 30 439 446
34. Gerhardt C. C., Romero I. A., Cancello R. et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol: 2001; 175 81 92 (Pubitemid 32372545)
35. Lu M. M., Wang J., Pan H. F. et al. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol Int: 2012; 32 1231 1233
36. Sewell D. L., Nacewicz B., Liu F. et al. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J Neuroimmunol: 2004; 155 55 63 (Pubitemid 39165777)
37. Ward P. A. Functions of C5a receptors. J Mol Med (Berl): 2009; 87 375 378
38. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol: 2010; 88 33 39
39. Xu H., Barnes G. T., Yang Q. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest: 2003; 112 1821 1830 (Pubitemid 38063705)
40. Harford K. A., Reynolds C. M., McGillicuddy F. C. et al. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc: 2011; 70 408 417
41. Maslowska M., Vu H., Phelis S. et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest: 1999; 29 679 686 (Pubitemid 29366715)
42. Cianflone K., Zhang X. J., Genest J. Jr et al. Plasma acylation-stimulating protein in coronary artery disease. Arterioscler Thromb Vasc Biol: 1997; 17 1239 1244 (Pubitemid 27329845)
43. Wu Y., Zhang J., Wen Y. et al. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril: 2009; 91 213 219
44. MacLaren R. E., Cui W., Lu H. et al. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics: 2010; 3 3